首頁 > 市場調查報告書 > 製藥

自體免疫疾病

市場調查報告書

商品編碼

1530993

纖維肌痛治療市場（治療類型：藥物和療法，配銷通路：醫院藥房、零售藥房和線上藥房）- 全球行業分析、規模、佔有率、成長、趨勢和預測，2024-2034 年

Fibromyalgia Treatment Market (Treatment Type: Medications and Therapies, and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

出版日期: 2024年06月11日 | 出版商:

Transparency Market Research | 英文 123 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

纖維肌痛治療市場 - 報告範圍

TMR 關於全球纖維肌痛治療市場的報告研究了過去以及當前的成長趨勢和機會，以獲得 2024 年至 2034 年預測期內市場指標的寶貴見解。 -2034年期間，考慮2024年為基準年，2034年為預測年。該報告也提供了2024年至2034年全球纖維肌痛治療市場的年複合成長率（CAGR%）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解纖維肌痛治療市場。

市場概況
2023年市場價值	19億美元
2034 年市場價值	29億美元
複合年成長率	3.8%

該報告深入研究了全球纖維肌痛治療市場的競爭格局。全球纖維肌痛治療市場的主要參與者已經確定，並且每位參與者都根據各種屬性進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球纖維肌痛治療市場參與者的屬性。

市場參與者 - 競爭矩陣（依公司層級和規模）
市佔率分析：依公司分類（2022 年）
公司簡介
- Pfizer Inc.
- Eli Lilly and Company
- AbbVie Inc.
- Tonix Pharmaceuticals
- Aptinyx Inc.
- Teva Pharmaceutical Industries Ltd.
- Novartis AG
- Sun Pharmaceutical Industries Limited
- Astellas Pharma Inc.
- Nipro Corporation

簡介目錄圖表

Product Code: TMRGL22697

Fibromyalgia Treatment Market - Scope of Report

TMR's report on the global fibromyalgia treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global fibromyalgia treatment market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global fibromyalgia treatment market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the fibromyalgia treatment market.

Market Snapshot
Market Value in 2023	US$ 1.9 Bn
Market Value in 2034	US$ 2.9 Bn
CAGR	3.8%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global fibromyalgia treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global fibromyalgia treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global fibromyalgia treatment market.

The report delves into the competitive landscape of the global fibromyalgia treatment market. Key players operating in the global fibromyalgia treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global fibromyalgia treatment market profiled in this report.

Key Questions Answered in Global fibromyalgia treatment Market Report:

What is the sales/revenue generated by fibromyalgia treatment across all regions during the forecast period?
What are the opportunities in the global fibromyalgia treatment market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2034?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

Fibromyalgia Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global fibromyalgia treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global fibromyalgia treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global fibromyalgia treatment market.

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Fibromyalgia Treatment Market

4. Market Overview

4.1. Introduction
- 4.1.1. Product Definition
- 4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. Global Fibromyalgia Treatment Market Analysis and Forecast, 2017-2031

5. Key Insights

5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry

6. Global Fibromyalgia Treatment Market Analysis and Forecast, by Treatment Type

6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Treatment Type, 2017-2031
- 6.3.1. Medications
  - 6.3.1.1. Pain Relievers
  - 6.3.1.2. Anti-Depressants
  - 6.3.1.3. Anti-Seizure Drugs
- 6.3.2. Therapies
  - 6.3.2.1. Physical Therapy
  - 6.3.2.2. Occupational Therapy
  - 6.3.2.3. Counselling
6.4. Market Attractiveness Analysis, by Treatment Type

7. Global Fibromyalgia Treatment Market Analysis and Forecast, by Distribution Channel

7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Distribution Channel, 2017-2031
- 7.3.1. Hospital Pharmacies
- 7.3.2. Retail Pharmacies
- 7.3.3. Online Pharmacies
7.4. Market Attractiveness Analysis, by Distribution Channel

8. Global Fibromyalgia Treatment Market Analysis and Forecast, by Region

8.1. Key Findings
8.2. Market Value Forecast, by Region, 2017-2031
- 8.2.1. North America
- 8.2.2. Europe
- 8.2.3. Asia Pacific
- 8.2.4. Latin America
- 8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region

9. North America Fibromyalgia Treatment Market Analysis and Forecast

9.1. Introduction
9.2. Key Findings
9.3. Market Value Forecast, by Treatment Type, 2017-2031
- 9.3.1. Medications
  - 9.3.1.1. Pain Relievers
  - 9.3.1.2. Anti-Depressants
  - 9.3.1.3. Anti-Seizure Drugs
- 9.3.2. Therapies
  - 9.3.2.1. Physical Therapy
  - 9.3.2.2. Occupational Therapy
  - 9.3.2.3. Counselling
9.4. Market Value Forecast, by Distribution Channel, 2017-2031
- 9.4.1. Hospital Pharmacies
- 9.4.2. Retail Pharmacies
- 9.4.3. Online Pharmacies
9.5. Market Value Forecast, by Country, 2017-2031
- 9.5.1. U.S.
- 9.5.2. Canada
9.6. Market Attractiveness Analysis
- 9.6.1. By Treatment Type
- 9.6.2. By Distribution Channel
- 9.6.3. By Country

10. Europe Fibromyalgia Treatment Market Analysis and Forecast

10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Treatment Type, 2017-2031
- 10.3.1. Medications
  - 10.3.1.1. Pain Relievers
  - 10.3.1.2. Anti-Depressants
  - 10.3.1.3. Anti-Seizure Drugs
- 10.3.2. Therapies
  - 10.3.2.1. Physical Therapy
  - 10.3.2.2. Occupational Therapy
  - 10.3.2.3. Counselling
10.4. Market Value Forecast, by Distribution Channel, 2017-2031
- 10.4.1. Hospital Pharmacies
- 10.4.2. Retail Pharmacies
- 10.4.3. Online Pharmacies
10.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 10.5.1. Germany
- 10.5.2. U.K.
- 10.5.3. France
- 10.5.4. Italy
- 10.5.5. Spain
- 10.5.6. Rest of Europe
10.6. Market Attractiveness Analysis
- 10.6.1. By Treatment Type
- 10.6.2. By Distribution Channel
- 10.6.3. By Country/Sub-region

11. Asia Pacific Fibromyalgia Treatment Market Analysis and Forecast

11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Treatment Type, 2017-2031
- 11.3.1. Medications
  - 11.3.1.1. Pain Relievers
  - 11.3.1.2. Anti-Depressants
  - 11.3.1.3. Anti-Seizure Drugs
- 11.3.2. Therapies
  - 11.3.2.1. Physical Therapy
  - 11.3.2.2. Occupational Therapy
  - 11.3.2.3. Counselling
11.4. Market Value Forecast, by Distribution Channel, 2017-2031
- 11.4.1. Hospital Pharmacies
- 11.4.2. Retail Pharmacies
- 11.4.3. Online Pharmacies
11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 11.5.1. China
- 11.5.2. Japan
- 11.5.3. India
- 11.5.4. Australia & New Zealand
- 11.5.5. Rest of Asia Pacific
11.6. Market Attractiveness Analysis
- 11.6.1. By Treatment Type
- 11.6.2. By Distribution Channel
- 11.6.3. By Country/Sub-region

12. Latin America Fibromyalgia Treatment Market Analysis and Forecast

12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Treatment Type, 2017-2031
- 12.3.1. Medications
  - 12.3.1.1. Pain Relievers
  - 12.3.1.2. Anti-Depressants
  - 12.3.1.3. Anti-Seizure Drugs
- 12.3.2. Therapies
  - 12.3.2.1. Physical Therapy
  - 12.3.2.2. Occupational Therapy
  - 12.3.2.3. Counselling
12.4. Market Value Forecast, by Distribution Channel, 2017-2031
- 12.4.1. Hospital Pharmacies
- 12.4.2. Retail Pharmacies
- 12.4.3. Online Pharmacies
12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.5.1. Brazil
- 12.5.2. Mexico
- 12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
- 12.6.1. By Treatment Type
- 12.6.2. By Distribution Channel
- 12.6.3. By Country/Sub-region

13. Middle East & Africa Fibromyalgia Treatment Market Analysis and Forecast

13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Treatment Type, 2017-2031
- 13.3.1. Medications
  - 13.3.1.1. Pain Relievers
  - 13.3.1.2. Anti-Depressants
  - 13.3.1.3. Anti-Seizure Drugs
- 13.3.2. Therapies
  - 13.3.2.1. Physical Therapy
  - 13.3.2.2. Occupational Therapy
  - 13.3.2.3. Counselling
13.4. Market Value Forecast, by Distribution Channel, 2017-2031
- 13.4.1. Hospital Pharmacies
- 13.4.2. Retail Pharmacies
- 13.4.3. Online Pharmacies
13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.5.1. GCC Countries
- 13.5.2. South Africa
- 13.5.3. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
- 13.6.1. By Treatment Type
- 13.6.2. By Distribution Channel
- 13.6.3. By Country/Sub-region

14. Competition Landscape

14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2022)
14.3. Company Profiles
- 14.3.1. Pfizer Inc.
  - 14.3.1.1. Company Overview
  - 14.3.1.2. Product Portfolio
  - 14.3.1.3. SWOT Analysis
  - 14.3.1.4. Financial Overview
  - 14.3.1.5. Strategic Overview
- 14.3.2. Eli Lilly and Company
  - 14.3.2.1. Company Overview
  - 14.3.2.2. Product Portfolio
  - 14.3.2.3. SWOT Analysis
  - 14.3.2.4. Financial Overview
  - 14.3.2.5. Strategic Overview
- 14.3.3. AbbVie Inc.
  - 14.3.3.1. Company Overview
  - 14.3.3.2. Product Portfolio
  - 14.3.3.3. SWOT Analysis
  - 14.3.3.4. Financial Overview
  - 14.3.3.5. Strategic Overview
- 14.3.4. Tonix Pharmaceuticals
  - 14.3.4.1. Company Overview
  - 14.3.4.2. Product Portfolio
  - 14.3.4.3. SWOT Analysis
  - 14.3.4.4. Financial Overview
  - 14.3.4.5. Strategic Overview
- 14.3.5. Aptinyx Inc.
  - 14.3.5.1. Company Overview
  - 14.3.5.2. Product Portfolio
  - 14.3.5.3. SWOT Analysis
  - 14.3.5.4. Financial Overview
  - 14.3.5.5. Strategic Overview
- 14.3.6. Teva Pharmaceutical Industries Ltd.
  - 14.3.6.1. Company Overview
  - 14.3.6.2. Product Portfolio
  - 14.3.6.3. SWOT Analysis
  - 14.3.6.4. Financial Overview
  - 14.3.6.5. Strategic Overview
- 14.3.7. Novartis AG
  - 14.3.7.1. Company Overview
  - 14.3.7.2. Product Portfolio
  - 14.3.7.3. SWOT Analysis
  - 14.3.7.4. Financial Overview
  - 14.3.7.5. Strategic Overview
- 14.3.8. Sun Pharmaceutical Industries Limited
  - 14.3.8.1. Company Overview
  - 14.3.8.2. Product Portfolio
  - 14.3.8.3. SWOT Analysis
  - 14.3.8.4. Financial Overview
  - 14.3.8.5. Strategic Overview
- 14.3.9. Astellas Pharma Inc.
  - 14.3.9.1. Company Overview
  - 14.3.9.2. Product Portfolio
  - 14.3.9.3. SWOT Analysis
  - 14.3.9.4. Financial Overview
  - 14.3.9.5. Strategic Overview
- 14.3.10. Nipro Corporation
  - 14.3.10.1. Company Overview
  - 14.3.10.2. Product Portfolio
  - 14.3.10.3. SWOT Analysis
  - 14.3.10.4. Financial Overview
  - 14.3.10.5. Strategic Overview

簡介目錄圖表

List of Tables

Table 01: Global Fibromyalgia Treatment Market Size (US$ Bn) Forecast, by Treatment Type, 2017-2031
Table 02: Global Fibromyalgia Treatment Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
Table 03: Global Fibromyalgia Treatment Market Size (US$ Bn) Forecast, by Region, 2017-2031
Table 04: North America Fibromyalgia Treatment Market Size (US$ Bn) Forecast, by Country, 2017-2031
Table 05: North America Fibromyalgia Treatment Market Size (US$ Bn) Forecast, by Treatment Type, 2017-2031
Table 06: North America Fibromyalgia Treatment Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
Table 07: Europe Fibromyalgia Treatment Market Size (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
Table 08: Europe Fibromyalgia Treatment Market Size (US$ Bn) Forecast, by Treatment Type, 2017-2031
Table 09: Europe Fibromyalgia Treatment Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
Table 10: Asia Pacific Fibromyalgia Treatment Market Size (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
Table 11: Asia Pacific Fibromyalgia Treatment Market Size (US$ Bn) Forecast, by Treatment Type, 2017-2031
Table 12: Asia Pacific Fibromyalgia Treatment Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
Table 13: Latin America Fibromyalgia Treatment Market Size (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
Table 14: Latin America Fibromyalgia Treatment Market Size (US$ Bn) Forecast, by Treatment Type, 2017-2031
Table 15: Latin America Fibromyalgia Treatment Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
Table 16: Middle East & Africa Fibromyalgia Treatment Market Size (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
Table 17: Middle East & Africa Fibromyalgia Treatment Market Size (US$ Bn) Forecast, by Treatment Type, 2017-2031
Table 18: Middle East & Africa Fibromyalgia Treatment Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031

List of Figures

Figure 01: Global Fibromyalgia Treatment Market Size (US$ Bn) and Distribution (%), by Region, 2022 and 2031
Figure 02: Global Fibromyalgia Treatment Market Revenue (US$ Bn), by Treatment Type, 2022
Figure 03: Global Fibromyalgia Treatment Market Value Share, by Treatment Type, 2022
Figure 04: Global Fibromyalgia Treatment Market Revenue (US$ Bn), by Distribution Channel, 2022
Figure 05: Global Fibromyalgia Treatment Market Value Share, by Distribution Channel, 2022
Figure 06: Global Fibromyalgia Treatment Market Value Share, by Region, 2022
Figure 07: Global Fibromyalgia Treatment Market Value (US$ Bn) Forecast, 2023-2031
Figure 08: Global Fibromyalgia Treatment Market Value Share Analysis, by Treatment Type, 2022 and 2031
Figure 09: Global Fibromyalgia Treatment Market Attractiveness Analysis, by Treatment Type, 2023-2031
Figure 10: Global Fibromyalgia Treatment Market Value Share Analysis, by Distribution Channel, 2022 and 2031
Figure 11: Global Fibromyalgia Treatment Market Attractiveness Analysis, by Distribution Channel, 2023-2031
Figure 12: Global Fibromyalgia Treatment Market Value Share Analysis, by Region, 2022 and 2031
Figure 13: Global Fibromyalgia Treatment Market Attractiveness Analysis, by Region, 2023-2031
Figure 14: North America Fibromyalgia Treatment Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2017-2031
Figure 15: North America Fibromyalgia Treatment Market Attractiveness Analysis, by Country, 2023-2031
Figure 16: North America Fibromyalgia Treatment Market Value Share Analysis, by Country, 2022 and 2031
Figure 17: North America Fibromyalgia Treatment Market Value Share Analysis, by Treatment Type, 2022 and 2031
Figure 18: North America Fibromyalgia Treatment Market Value Share Analysis, by Distribution Channel, 2022 and 2031
Figure 19: North America Fibromyalgia Treatment Market Attractiveness Analysis, by Treatment Type, 2023-2031
Figure 20: North America Fibromyalgia Treatment Market Attractiveness Analysis, by Distribution Channel, 2023-2031
Figure 21: Europe Fibromyalgia Treatment Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2017-2031
Figure 22: Europe Fibromyalgia Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 23: Europe Fibromyalgia Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 24: Europe Fibromyalgia Treatment Market Value Share Analysis, by Treatment Type, 2022 and 2031
Figure 25: Europe Fibromyalgia Treatment Market Value Share Analysis, by Distribution Channel, 2022 and 2031
Figure 26: Europe Fibromyalgia Treatment Market Attractiveness Analysis, by Treatment Type, 2023-2031
Figure 27: Europe Fibromyalgia Treatment Market Attractiveness Analysis, by Distribution Channel, 2023-2031
Figure 28: Asia Pacific Fibromyalgia Treatment Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2017-2031
Figure 29: Asia Pacific Fibromyalgia Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 30: Asia Pacific Fibromyalgia Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 31: Asia Pacific Fibromyalgia Treatment Market Value Share Analysis, by Treatment Type, 2022 and 2031
Figure 32: Asia Pacific Fibromyalgia Treatment Market Value Share Analysis, by Distribution Channel, 2022 and 2031
Figure 33: Asia Pacific Fibromyalgia Treatment Market Attractiveness Analysis, by Treatment Type, 2023-2031
Figure 34: Asia Pacific Fibromyalgia Treatment Market Attractiveness Analysis, by Distribution Channel, 2023-2031
Figure 35: Latin America Fibromyalgia Treatment Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2017-2031
Figure 36: Latin America Fibromyalgia Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 37: Latin America Fibromyalgia Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 38: Latin America Fibromyalgia Treatment Market Value Share Analysis, by Treatment Type, 2022 and 2031
Figure 39: Latin America Fibromyalgia Treatment Market Value Share Analysis, by Distribution Channel, 2022 and 2031
Figure 40: Latin America Fibromyalgia Treatment Market Attractiveness Analysis, by Treatment Type, 2023-2031
Figure 41: Latin America Fibromyalgia Treatment Market Attractiveness Analysis, by Distribution Channel, 2023-2031
Figure 42: Middle East & Africa Fibromyalgia Treatment Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2017-2031
Figure 43: Middle East & Africa Fibromyalgia Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 44: Middle East & Africa Fibromyalgia Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 45: Middle East & Africa Fibromyalgia Treatment Market Value Share Analysis, by Treatment Type, 2022 and 2031
Figure 46: Middle East & Africa Fibromyalgia Treatment Market Value Share Analysis, by Distribution Channel, 2022 and 2031
Figure 47: Middle East & Africa Fibromyalgia Treatment Market Attractiveness Analysis, by Treatment Type, 2023-2031
Figure 48: Middle East & Africa Fibromyalgia Treatment Market Attractiveness Analysis, by Distribution Channel, 2023-2031